Log In
BCIQ
Print this Print this
 

2890457

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionEndogenous gut peptide stimulator
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationObesity
Indication DetailsTreat obesity
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today